Universal Health Services, Inc. (UHS) Stock: Tracking the Weekly Performance

Biotech Stocks to buy

The stock of Universal Health Services, Inc. (UHS) has seen a 10.05% increase in the past week, with a 6.40% gain in the past month, and a 20.38% flourish in the past quarter. The volatility ratio for the week is 2.58%, and the volatility levels for the past 30 days are at 3.00% for UHS. The simple moving average for the last 20 days is 8.79% for UHS’s stock, with a simple moving average of 23.63% for the last 200 days.

Is It Worth Investing in Universal Health Services, Inc. (NYSE: UHS) Right Now?

Universal Health Services, Inc. (NYSE: UHS) has a higher price-to-earnings ratio of 14.65x compared to its average ratio, The 36-month beta value for UHS is at 1.28. Analysts have varying views on the stock, with 8 analysts rating it as a “buy,” 3 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for UHS is 56.80M, and currently, shorts hold a 1.78% of that float. The average trading volume for UHS on July 25, 2024 was 690.68K shares.

UHS) stock’s latest price update

Universal Health Services, Inc. (NYSE: UHS)’s stock price has soared by 7.39 in relation to previous closing price of 185.97. Nevertheless, the company has seen a gain of 10.05% in its stock price over the last five trading days. zacks.com reported 2024-07-24 that Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Analysts’ Opinion of UHS

Many brokerage firms have already submitted their reports for UHS stocks, with Robert W. Baird repeating the rating for UHS by listing it as a “Outperform.” The predicted price for UHS in the upcoming period, according to Robert W. Baird is $236 based on the research report published on June 26, 2024 of the current year 2024.

Robert W. Baird, on the other hand, stated in their research note that they expect to see UHS reach a price target of $198. The rating they have provided for UHS stocks is “Neutral” according to the report published on May 30th, 2024.

UBS gave a rating of “Buy” to UHS, setting the target price at $226 in the report published on May 20th of the current year.

UHS Trading at 8.48% from the 50-Day Moving Average

After a stumble in the market that brought UHS to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 2.93% of gains for the given period.

Volatility was left at 3.00%, however, over the last 30 days, the volatility rate increased by 2.58%, as shares surge +5.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.25% upper at present.

During the last 5 trading sessions, UHS rose by +10.46%, which changed the moving average for the period of 200-days by +58.60% in comparison to the 20-day moving average, which settled at $184.12. In addition, Universal Health Services, Inc. saw 31.01% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at UHS starting from Nimetz Warren J., who sale 725 shares at the price of $180.32 back on May 16 ’24. After this action, Nimetz Warren J. now owns 3,971 shares of Universal Health Services, Inc., valued at $130,732 using the latest closing price.

Singer Maria Ruderman, the Director of Universal Health Services, Inc., sale 1,689 shares at $179.29 during a trade that took place back on May 14 ’24, which means that Singer Maria Ruderman is holding 3,168 shares at $302,827 based on the most recent closing price.

Stock Fundamentals for UHS

Current profitability levels for the company are sitting at:

  • 0.09 for the present operating margin
  • 0.48 for the gross margin

The net margin for Universal Health Services, Inc. stands at 0.06. The total capital return value is set at 0.11. Equity return is now at value 14.86, with 6.72 for asset returns.

Based on Universal Health Services, Inc. (UHS), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 0.79. The interest coverage ratio of the stock is 5.97.

Currently, EBITDA for the company is 1.74 billion with net debt to EBITDA at 2.82. When we switch over and look at the enterprise to sales, we see a ratio of 1.17. The receivables turnover for the company is 6.37for trailing twelve months and the total asset turnover is 1.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.28.

Conclusion

In conclusion, Universal Health Services, Inc. (UHS) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts